Axsome Therapeutics, Inc. (AXSM) Income Annual - Discounting Cash Flows
AXSM
Axsome Therapeutics, Inc.
AXSM (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing 2026-02-23 2026-02-23 2025-02-18 2024-02-23 2023-02-28 2022-03-01 2021-03-01 2020-03-12 2019-03-15 2018-03-07 2017-03-07 2016-03-24 2014-12-31 2013-12-31
Revenue 638.5 638.5 385.7 270.6 50.04 0 0 0 0 0 0 0 0 0
Cost of Revenue 47.48 47.48 33.3 26.07 5.2 0 0 0.037 0.049 0.043 0.02 0.004 0 0
Gross Profit 591 591 352.4 244.5 44.84 0 0 -0.037 -0.049 -0.043 -0.02 -0.004 0 0
Operating Expenses 760.3 760.3 633 476.4 224.6 124.7 99.14 67.21 32.8 27.12 27.52 9.19 5.67 1.84
Research & Development 183.3 183.3 187.1 97.94 57.95 58.06 70.24 53.65 23.5 19.96 21.2 6.78 4.28 1.54
Selling, General and Administrative 570.6 570.6 411.4 323.1 159.3 66.65 28.9 13.6 9.35 7.21 6.34 2.42 1.39 0.304
Other Operating Expenses 6.38 6.38 34.52 55.29 7.44 0 0 -0.037 -0.049 -0.043 -0.02 -0.004 0 0
Operating Income -169.2 -169.2 -280.6 -231.8 -179.8 -124.7 -99.14 -67.25 -32.85 -27.16 -27.54 -9.2 -5.67 -1.84
Net Non-Operating Interest -4.52 2.81 -6.57 -6.45 -7.33 -5.7 0 0 -1.13 -1.34 -0.132 0 0 -0.327
Interest Income 2.04 9.37 0 0 0 0 2.57 1.24 0 0 0 0.915 2.23 0
Interest Expense 6.56 6.56 6.57 6.45 7.33 5.7 2.57 1.24 1.13 1.34 0.132 0.915 2.23 0.327
Equity & Other Income/(Expense) -9.95 -17.28 0 0 0 0 -3.76 -1.1 3.01 -0.439 0.474 -1.36 -0.329 0
Income Before Tax -183.7 -183.7 -287.1 -238.3 -187.1 -130.4 -102.9 -68.35 -30.97 -28.94 -27.2 -10.56 -6 -2.17
Income Tax Expense -0.53 -0.53 0.085 0.96 0 0 0 0 0 0 0 1.36 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 0 0.291 0 0
Net Income -183.2 -183.2 -287.2 -239.2 -187.1 -130.4 -102.9 -68.35 -30.97 -28.94 -27.2 -12.21 -6 -2.17
Depreciation and Amortization 8.38 9.06 7.96 6.83 4.4 0.076 0.078 0.037 0.049 0.043 0.02 0.004 2.93 1.84
EBITDA -160.9 -160.2 -272.6 -225 -175.4 -124.6 -99.06 -67.21 -32.8 -27.12 -27.52 -9.19 -2.74 0
Earnings Per Share (EPS) -3.69 -3.68 -5.99 -5.27 -4.6 -3.47 -2.83 -2.05 -1.15 -1.27 -1.42 -0.88 -0.47 -0.28
Diluted Earnings Per Share -3.69 -3.68 -5.99 -5.27 -4.6 -3.47 -2.83 -2.05 -1.15 -1.27 -1.42 -0.88 -0.47 -0.28
Weighted Average Shares Outstanding 50.63 49.75 47.91 45.43 40.66 37.62 37.21 34.02 26.88 22.76 19.15 11.95 12.72 7.82
Diluted Weighted Average Shares Outstanding 50.63 49.75 47.91 45.43 40.66 37.62 37.21 34.02 26.88 22.76 19.15 11.95 12.72 7.82
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program